Brex reports that effective expense receipt tracking can streamline financial processes, reduce errors, and enhance ...

Oncolytics Biotech ( ($ONCY) ) has shared an update. On November 12, 2025, Oncolytics Biotech Inc. released its financial results for the three ...

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025. The quarter marked continued ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

MOUNT LAUREL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) (the "Company”) today reported financial results for the fourth quarter and full year ended September 27, ...

Continued execution on collaborations and exploratory investigator-initiated studies with institutional partners Secured net proceeds of approximately $3.9 million from October 2025 offering ...

New housing under construction in New Hampshire, March 2023. Housing was found to be the main expense squeezing families. The median household income in New Hampshire falls nearly $2000 short of ...

Record Net Income of $5.6 Million for the Quarter; Retired All $41 Million of Senior and Seller Debt; Retired All Preferred Shares with Redemption Value of $27 Million; and Increased Shareholder ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of ...

November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the ...